Clinical Trial Update: Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the sonographic efficacy of rituximab in rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED